- Open
- 12032.00
- High
- 12124.00
- Low
- 11890.00
- Close
- 11902.00
- Change
- -278.00 (-2.28%)
- Volume
- 1,576,534
AstraZeneca plc is a global, science-led pharmaceutical company focused on the research, development, and commercialization of prescription medicines. It operates primarily in the oncology, bio-pharmaceuticals, and rare disease sectors, delivering a diverse portfolio of products aimed at improving patient outcomes. The company generates revenue through product sales, alliance revenue, and collaboration revenue, serving a wide range of customers across various geographies, including the United States, Europe, and emerging markets.
AstraZeneca plc is a global, science-led pharmaceutical company focused on the research, development, and commercialization of prescription medicines. It operates primarily in the oncology, bio-pharmaceuticals, and rare disease sectors, delivering a diverse portfolio of products aimed at improving patient outcomes. The company generates revenue through product sales, alliance revenue, and collaboration revenue, serving a wide range of customers across various geographies, including the United States, Europe, and emerging markets.
| Issuer | Mkt cap | 1Y |
|---|---|---|
AZNAstrazeneca plc | £184.61bn | -0.0% |
| £75.13bn | +0.1% | |
| £4.10bn | -0.1% | |
| £3.37bn | -0.1% | |
| £276m | -0.1% | |
| £65m | -0.0% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
AZNAstrazeneca plc | £184.61bn | -0.0% |
| £75.13bn | +0.1% | |
| £4.10bn | -0.1% | |
| £3.37bn | -0.1% | |
| £276m | -0.1% | |
| £65m | -0.0% |